GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Teva Pharmaceutical Industries
Teva is an Israeli pharmaceutical giant and the world's largest generic drug maker. Its stock chart is a tale of deep crisis, driven by massive debt, price pressure on generics, and legal challenges related to opioids.
Share prices of companies in the market segment - Pharma holding
Teva is one of the world's largest generic drug manufacturers. We classify it as a Pharma Holding. The chart below shows the overall dynamics of this challenging market, where the company is struggling with pricing pressure and massive debt from past acquisitions.
Broad Market Index - GURU.Markets
Teva Pharmaceutical is one of the world's largest generic drug manufacturers and a developer of original drugs. It is a component of the GURU.Markets index. The chart below shows the US market. See how this Israeli company's stock compares to the US market.
Change in the price of a company, segment, and market as a whole per day
TEVA - Daily change in the company's share price Teva Pharmaceutical Industries
Teva is a global leader in the production of generic and specialty pharmaceuticals. Its daily share price change is a measure of volatility and sensitivity to news in the pharmaceutical industry. This metric is an important component of formulas on System.GURU.Markets, where it is used for in-depth analysis.
Daily change in the price of a set of shares in a market segment - Pharma holding
Teva Pharmaceutical Industries Limited is a global leader in generic drug production. This chart shows the average daily volatility of the pharmaceutical sector. Comparing this to TEVA's performance helps understand how price competition and debt burden affect its stability.
Daily change in the price of a broad market stock, index - GURU.Markets
Teva Pharmaceutical is an Israeli giant and one of the world's largest generic drug manufacturers. The company has undergone a challenging period of restructuring. The chart below shows overall market volatility, providing context for assessing how Teva is handling internal and external challenges.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Teva Pharmaceutical Industries
Teva, one of the world's largest generic drug makers, has been undergoing a complex restructuring over the past year in an effort to reduce debt. Its year-over-year share price performance, shown in the chart, reflects the market's assessment of this turnaround strategy and the situation in the generic drug market.
Annual dynamics of market capitalization of the market segment - Pharma holding
Teva Pharmaceutical Industries Ltd. is a global leader in generic pharmaceuticals. The company is undergoing a restructuring to address significant debt and pricing pressure in the generics market. The chart will show how successful these efforts are in stabilizing the business and returning to growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Teva Pharmaceutical is one of the world's largest generic drug manufacturers. The company has navigated a challenging period of restructuring and litigation. Its performance reflects the state of the generic drug market and the company's success in reducing its debt burden and developing new specialized drugs.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Teva Pharmaceutical Industries
Teva Pharmaceutical's chart reflects its dual nature: the stability of its generics business and the risks associated with new drug development. Monthly fluctuations reflect the company's reaction to patent court rulings, pricing pressure on generics, and debt restructuring news.
Monthly dynamics of market capitalization of the market segment - Pharma holding
Teva Pharmaceutical Industries is a global leader in generic drug production and a developer of specialty medications. The dynamics of the pharmaceutical sector, shown in the chart, reflect both pricing pressure on generics and patents on new drugs. This allows us to assess how Teva balances these two business models in a challenging market environment.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Shares of major generic drug makers often follow a unique trajectory, driven by patent disputes, pricing pressure, and competition. The chart below illustrates these general market trends. How does Teva Pharmaceutical's story differ from the general landscape, reflecting the unique challenges of the pharmaceutical industry?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Teva Pharmaceutical Industries
Teva Pharmaceutical, one of the world's largest generic drug makers, whose weekly stock price reflects price competition in the generic drug market and litigation news. Success in promoting original-brand drugs also influences short-term sentiment.
Weekly dynamics of market capitalization of the market segment - Pharma holding
Teva, as one of the largest generic drug manufacturers, is a barometer for its segment of the pharmaceutical industry. The chart compares its performance with the industry as a whole, showing how susceptible it is to issues common to all generic drug manufacturers, such as pricing pressure and patent disputes.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Teva Pharmaceutical is one of the world's largest generic drug manufacturers. This chart will help you assess how Teva's stock is performing relative to the market. Is its business defensive due to drug demand, or are its own challenges making it more volatile?
Market capitalization of the company, segment and market as a whole
TEVA - Market capitalization of the company Teva Pharmaceutical Industries
Teva's market capitalization is a financial chronicle of the rise and fall of the generics giant. This Israeli drugmaker's chart reflects not only the erosion of generic drug prices but also its years-long struggle with debt and legal issues. The chart's movements reflect investors' attempts to gauge the prospects of its complex turnaround.
TEVA - Share of the company's market capitalization Teva Pharmaceutical Industries within the market segment - Pharma holding
Teva Pharmaceutical is one of the world's largest producers of generic and specialty drugs. Its market capitalization reflects its vast production capacity and ability to make medications more affordable. The chart below shows the weight of this Israeli giant in the global pharmaceutical industry.
Market capitalization of the market segment - Pharma holding
Teva Pharmaceutical is the world's leading producer of generic drugs. The chart below shows the total market capitalization of the entire pharmaceutical industry. Its dynamics reflect pricing pressure in the generics market and the ongoing need for affordable medications.
Market capitalization of all companies included in a broad market index - GURU.Markets
Teva is a global leader in generics, making medicines accessible to millions of people. Its market capitalization chart tells a complex story of pricing pressure, patent wars, and attempted transformation. It shows how a company with a huge production volume is fighting for its share of the pharmaceutical market.
Book value capitalization of the company, segment and market as a whole
TEVA - Book value capitalization of the company Teva Pharmaceutical Industries
The book value of Teva, the generics giant, is represented by its numerous factories and extensive product portfolio. The chart below may show a decline, reflecting asset write-downs and restructuring in an attempt to cope with massive debt. This is a story of asset transformation.
TEVA - Share of the company's book capitalization Teva Pharmaceutical Industries within the market segment - Pharma holding
Teva is one of the world's largest generic drug manufacturers. Its competitive advantage lies in its massive production scale, enabled by its global network of factories. The sector share chart shows how much of the global pharmaceutical manufacturing infrastructure this giant controls.
Market segment balance sheet capitalization - Pharma holding
The pharmaceutical industry, as the chart shows, requires enormous investment in manufacturing facilities. Teva, as the global leader in generics, is one of the pillars of this capital-intensive industry. Its business model is based on scale, which is enabled by a global network of manufacturing sites.
Book value of all companies included in the broad market index - GURU.Markets
Teva is one of the world's largest generic drug manufacturers, making medicines accessible to millions. The company's assets include massive pharmaceutical plants operating on an industrial scale across the globe. The chart below shows the physical weight of this "pharmacy for the world."
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is the world's largest generic drug maker. Its valuation has long been significantly below its book value due to massive debt and legal challenges related to the opioid crisis.
Market to book capitalization ratio in a market segment - Pharma holding
Teva Pharmaceutical Industries is a global leader in generic drug production. Its business requires large production facilities. This chart shows how the market values the company relative to its assets, which is often at a discount due to its debt burden and legal risks.
Market to book capitalization ratio for the market as a whole
Teva Pharmaceutical is a global leader in generic drug production and also has a portfolio of original drugs. The generic business is characterized by high volumes and low prices, which requires scale. The chart shows how the market values this business model, which is less profitable than that of innovative drug developers.
Debts of the company, segment and market as a whole
TEVA - Company debts Teva Pharmaceutical Industries
Teva Pharmaceutical, one of the world's largest generic drug makers, is managing a massive debt pile left over from a failed acquisition. Its financial strategy in recent years has been entirely focused on reducing its debt burden through asset sales and streamlining operations. This chart tells the story of the consequences of a major corporate mistake.
Market segment debts - Pharma holding
Teva Pharmaceutical is one of the world's largest generic drug manufacturers. The company accumulated a massive debt following a major acquisition several years ago. This chart clearly shows how Teva has since focused on reducing its debt load, a key factor in its financial strategy and survival in the competitive pharmaceutical market.
Market debt in general
Teva Pharmaceutical Industries is one of the world's largest generic drug makers. The company faces massive debt following a failed acquisition and legal challenges. This chart provides context for Teva's herculean efforts to restructure, reduce debt, and stabilize its business amid fierce competition in the generic drug market.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Teva Pharmaceutical Industries
Teva Pharmaceutical, a global leader in generic drugs, has struggled for years with massive debt incurred after a failed acquisition. This chart shows its current debt load. Analyzing this trend is key to understanding how close the company is to financial recovery and a return to sustainable growth.
Market segment debt to market segment book capitalization - Pharma holding
Teva Pharmaceutical is a global leader in generic and specialty pharmaceuticals. This chart shows the debt burden in the pharmaceutical industry. It helps understand how companies manage their balance sheets after major acquisitions and amid pricing pressure in the generic drug market, reflecting Teva's path to recovery.
Debt to book value of all companies in the market
Teva is a global leader in generic drugs. This chart reflects the overall debt burden across the market. It helps understand how a company with a high debt burden manages its balance sheet given the overall economic environment and changing interest rates, which impact the cost of servicing that debt.
P/E of the company, segment and market as a whole
P/E - Teva Pharmaceutical Industries
This chart of Teva Pharmaceutical, one of the world's largest generic drug manufacturers, shows its business valuation in the face of pricing pressure. The company's profitability depends on the successful launch of new generics and managing its massive debt. The metric reflects investor skepticism or optimism about its ability to recover.
P/E of the market segment - Pharma holding
Teva Pharmaceutical is one of the world's largest producers of generics (analogs of branded drugs) and a developer of specialized medications. The company makes medications more affordable. This chart shows the average valuation in the pharmaceutical industry, reflecting both pricing pressure in the generics market and the potential of the company's innovative products.
P/E of the market as a whole
Teva Pharmaceutical is one of the world's largest generic drug manufacturers and a developer of original drugs. This chart reflects overall market sentiment. Comparisons with it help understand how investors view the company's challenging situation: whether they see potential in restructuring and a new drug portfolio, or whether they are deterred by massive debt and lawsuits.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Teva Pharmaceutical Industries
Teva Pharmaceutical is one of the world's largest generic drug manufacturers, also boasting a portfolio of original drugs. This chart reflects market expectations for the future of the pharmaceutical industry. The valuation depends on price competition in the generic market, the success of new product launches, and the company's ability to manage its massive debt burden and lawsuits.
%20P%2FE%20Teva%20Pharmaceutical%20Industries&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Teva-Pharmaceutical-Industries&v=1772662843650 "Chart of the company's future (projected) P/E Teva Pharmaceutical Industries")
Future (projected) P/E of the market segment - Pharma holding
Teva Pharmaceutical is one of the world's largest generic drug manufacturers and a developer of original drugs. The chart shows how Teva's future profit expectations compare to those for the pharmaceutical sector. This reflects market sentiment on the company's ability to manage its debt burden and pricing pressure in the generics market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-holding&v=1772662843675 "Future (projected) P/E graph of the market segment - Pharma holding")
Future (projected) P/E of the market as a whole
Teva Pharmaceutical Industries is one of the world's largest generic drug manufacturers. Its business depends on the expiration of patents on original drugs. This graph of overall market expectations is less important for Teva than the dynamics of the healthcare sector. However, the overall state of the economy affects the solvency of healthcare systems.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772662843684 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Teva Pharmaceutical Industries
Teva Pharmaceutical is one of the world's largest producers of generic drugs (analogs of branded drugs). The company also develops its own drugs. Its profits depend on the successful launch of new generics and competition in this area. This chart illustrates the challenges and opportunities in the affordable and accessible pharmaceuticals industry.
Profit of companies in the market segment - Pharma holding
Teva Pharmaceutical is a global leader in the production of generics (drug analogs) and some brand-name drugs. The company's profitability depends on price competition in the generics market and patent expirations. This chart reflects the complex processes in the pharmaceutical industry, where pricing pressure in one segment impacts the overall profitability of the entire sector.
Overall market profit
Teva Pharmaceutical is a global leader in generic medicines. Demand for generics is stable and even grows during economic downturns, as healthcare systems and consumers seek to reduce costs. This makes Teva's business countercyclical to overall economic dynamics, as shown in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Teva Pharmaceutical Industries
Teva Pharmaceutical is one of the world's largest producers of generic and specialty pharmaceuticals. This chart shows expectations for future profits. Analysts' forecasts depend on price competition in the generics market, the success of its branded drugs, such as Austedo, and progress in reducing its debt burden.
%20profit%20of%20the%20company%20Teva%20Pharmaceutical%20Industries&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Teva-Pharmaceutical-Industries&v=1772662843832 "Graph of future (projected) profit of the company Teva Pharmaceutical Industries")
Future (predicted) profit of companies in the market segment - Pharma holding
Teva Pharmaceutical Industries is one of the world's largest producers of generic and specialty pharmaceuticals. This chart shows the profit forecast for the entire pharmaceutical industry. It reflects expectations for price competition in the generics market and the potential of new biologics, which are key to assessing Teva's strategy and future.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-holding&v=1772662843870 "Graph of future (predicted) profits of companies in a market segment - Pharma holding")
Future (predicted) profit of the market as a whole
Teva Pharmaceutical Industries is one of the world's largest producers of generic drugs. Its business is often countercyclical: during periods of economic downturn, as predicted in this chart, healthcare systems and patients may more actively switch to cheaper generics to save money, which benefits Teva.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772662843904 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Teva Pharmaceutical Industries
Teva Pharmaceutical is a global leader in generic drugs, as well as a manufacturer of original medications. The company's revenue depends on the successful launch of new generics and sales of branded medications. This chart shows how investors value its business amid pricing pressure in the generics market.
P/S market segment - Pharma holding
Teva Pharmaceutical is a global leader in generic drug production and also has a portfolio of original drugs. The company operates in a vast but competitive market. This chart shows the average revenue estimate in the pharmaceutical sector, which helps understand how the market views Teva's scale and its recovery strategy.
P/S of the market as a whole
Teva Pharmaceutical is one of the world's largest producers of generics (analogs of branded drugs), as well as a developer of its own drugs. The company's business depends on patent expirations and price competition. This chart shows how the market values the pharmaceutical giant's enormous but low-margin revenues compared to other sectors.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Teva Pharmaceutical Industries
Teva Pharmaceutical is one of the world's largest generic drug manufacturers, as well as a portfolio of original drugs. Future revenue depends on the successful launch of new generics and sales of branded drugs. This chart shows how investors assess its ability to compete in the generics market and manage debt.
%20P%2FS%20Teva%20Pharmaceutical%20Industries&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Teva-Pharmaceutical-Industries&v=1772662844018 "The graph of the company's future (projected) P/S Teva Pharmaceutical Industries")
Future (projected) P/S of the market segment - Pharma holding
Teva Pharmaceutical is a global leader in generic medicines, as well as a portfolio of original drugs. The company faces challenges related to generic pricing pressure and patent cliffs. This chart shows how the market values its future revenue, reflecting its efforts to restructure and stabilize its business.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20holding&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-holding&v=1772662844056 "Future (projected) P/S market segment graph - Pharma holding")
Future (projected) P/S of the market as a whole
Teva Pharmaceutical is a global leader in generic drugs. The company's business is less cyclical but benefits from the overall desire of healthcare systems to control costs. At the same time, economic optimism, reflected in the chart, could support demand for its branded drugs and facilitate debt refinancing.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772662844090 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Teva Pharmaceutical Industries
Teva Pharmaceutical is a global leader in the production of generics (analogs of branded drugs) and a developer of original drugs. The company's revenue comes from sales of a vast portfolio of affordable generics and several branded medications. The chart shows total revenue, which reflects competition in the generics market and patent cycles.
Sales of companies in the market segment - Pharma holding
Teva Pharmaceutical is one of the world's largest manufacturers of generic and specialty pharmaceuticals. The company's business is divided into three regional segments, selling both generic and brand-name medications, such as those for migraine and multiple sclerosis. This chart shows the state of the global pharmaceutical market, where Teva plays a key role in providing affordable medicines.
Overall market sales
Teva Pharmaceutical is a global leader in generic drugs and also has a portfolio of brand-name medications. Demand for generics rises when healthcare systems seek cost-saving measures, which can occur during economic downturns. Therefore, Teva's business may be countercyclical to overall economic activity in this chart.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Teva Pharmaceutical Industries
Teva Pharmaceutical is one of the world's largest generic drug manufacturers and a developer of original drugs. The company has faced challenges but is undergoing restructuring. This chart shows how analysts assess Teva's ability to stabilize its generics business and successfully launch new branded drugs.
%20sales%20of%20the%20company%20Teva%20Pharmaceutical%20Industries&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Teva-Pharmaceutical-Industries&v=1772662844226 "Schedule of future (projected) sales of the company Teva Pharmaceutical Industries")
Future (projected) sales of companies in the market segment - Pharma holding
Teva Pharmaceutical is one of the world's largest generic drug manufacturers and a developer of original drugs. This chart illustrates expectations for the pharmaceutical industry. It helps analyze how the company is coping with pricing pressure in the generic market and legal challenges while simultaneously trying to bring new drugs to market.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-holding&v=1772662844287 "Schedule of future (projected) sales of companies in the market segment - Pharma holding")
Future (projected) sales of the market as a whole
Teva Pharmaceutical, one of the world's largest generic drug manufacturers, sees this chart as a reflection of global healthcare trends. Economic growth, as projected here, allows healthcare systems around the world to expand access to medications. This increases demand for affordable generics, which are the core of Teva's business, as it strives to reduce treatment costs.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772662844312 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Teva Pharmaceutical Industries
Teva Pharmaceutical is one of the world's largest generic drug manufacturers. Their business is producing affordable alternatives to original drugs. This chart illustrates how the company operates in a highly competitive price environment, where profitability requires massive production volumes and maximum operational efficiency.
Market segment marginality - Pharma holding
Teva Pharmaceutical is one of the world's largest producers of generics (analogs of branded drugs), and also has a portfolio of original drugs. This chart shows its operating efficiency. Profitability in the generics business depends heavily on production scale, cost control, and the ability to be first to market with generic versions of popular drugs.
Market marginality as a whole
Teva Pharmaceutical is a global leader in generic drug production. The company's business depends on patent expirations on original drugs and pricing pressure in the generics market. This overall profitability curve has little impact on Teva, whose profitability is determined by competition and the efficiency of its own manufacturing operations.
Employees in the company, segment and market as a whole
Number of employees in the company Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a global giant in generic drug production. This chart is likely to show a downward trend in recent years. This reflects the company's long and complex restructuring, aimed at reducing the massive debt incurred after a major acquisition and adapting to increasing pricing pressure in the generics market.
Share of the company's employees Teva Pharmaceutical Industries within the market segment - Pharma holding
Teva Pharmaceutical is a global leader in generic drug production and a developer of innovative drugs. This chart illustrates the scale of this pharmaceutical giant's talent pool. It reflects the enormous share of specialists in the global pharmaceutical industry, from synthetic chemists to regulatory specialists, that Teva brings together.
Number of employees in the market segment - Pharma holding
Teva Pharmaceutical is one of the world's largest manufacturers of generic and specialty pharmaceuticals. This chart illustrates the scale of employment in the pharmaceutical industry. The sheer number of employees worldwide reflects the complexity of producing and distributing a broad portfolio of affordable medicines that are the foundation of healthcare systems.
Number of employees in the market as a whole
Teva Pharmaceutical Industries is a global leader in generic drug production and also has a portfolio of original drugs. Their business is dual-faceted. This overall employment chart reflects the state of healthcare systems. Employment growth supports demand for medications, while economic pressure forces healthcare systems to switch to Teva's more affordable generics.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Teva Pharmaceutical Industries (TEVA)
Teva Pharmaceutical is a global leader in generic drug production. This chart illustrates a business model based on scale. The relatively modest capitalization per employee reflects the fact that producing billions of tablets and competing on price requires large factories and a significant workforce, while generic drug margins are lower than those of branded drugs.
%20of%20the%20company%20Teva%20Pharmaceutical%20Industries%20(TEVA)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Teva-Pharmaceutical-Industries-TEVA&v=1772662844519 "Chart of market capitalization per employee (in thousands of dollars) of the company Teva Pharmaceutical Industries (TEVA)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma holding
Teva (TEVA) is a global giant in the production of generics (copies of drugs), struggling to balance this low-margin, high-volume business with the development of its own branded drugs. This chart shows the market value per employee in this "heavy" and low-margin pharmaceutical model.
%20by%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-holding&v=1772662844528 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma holding")
Market capitalization per employee (in thousands of dollars) for the overall market
Teva Pharmaceutical is a global leader in generic and specialty pharmaceuticals. Its business combines high-volume production with scientific development. This chart shows the market value each employee creates in the complex and highly competitive pharmaceutical industry.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772662844536 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Teva Pharmaceutical Industries (TEVA)
Teva Pharmaceutical is a global leader in generic drugs, also boasting a portfolio of brand-name drugs. The generics market is characterized by low margins and high volumes. This chart demonstrates how effectively Teva manages its massive manufacturing and R&D workforce. It reflects their ability to compete in a sector with high cost pressure.
%20Chart%20Teva%20Pharmaceutical%20Industries%20(TEVA)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Teva-Pharmaceutical-Industries-TEVA&v=1772662844591 "Company Profit Per Employee (in thousands of dollars) Chart Teva Pharmaceutical Industries (TEVA)")
Profit per employee (in thousands of dollars) in the market segment - Pharma holding
Teva is a global leader in generic drug production, but also produces original-brand drugs. This chart shows the benchmark for "Pharma Holdings." This benchmark is a compromise. It balances the low-margin but high-volume generic business with the high-margin but risky R&D business.
%20in%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-holding&v=1772662844622 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma holding")
Profit per employee (in thousands of dollars) for the market as a whole
Teva Pharmaceutical is one of the world's largest producers of generic drugs, as well as some brand-name medications. The generics market is characterized by intense competition and pricing pressure. This chart reflects how effectively Teva manages its vast product portfolio and manufacturing capacity to remain profitable.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772662844643 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Teva Pharmaceutical Industries (TEVA)
Teva Pharmaceutical is one of the world's largest generic drug manufacturers. This chart reflects the specifics of the generic drug business. Efficiency is achieved through production scale and the ability to quickly bring cheaper alternatives to original drugs to market after their patents expire.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Teva-Pharmaceutical-Industries-TEVA&v=1772662844668 "Sales chart per company employee Teva Pharmaceutical Industries (TEVA)")
Sales per employee in the market segment - Pharma holding
Teva Pharmaceutical is a global leader in generic drug production. It's a highly competitive, low-margin business that requires scale and production efficiency. This chart shows the industry average per employee income. It helps assess how productive Teva's factories are compared to competitors.
Sales per employee for the market as a whole
Teva Pharmaceutical is one of the world's largest generic drug manufacturers. Their business relies on high-volume, efficient production. They also have several original-brand drugs (such as Copaxone). This chart shows how much revenue their factories generate in the face of pricing pressure in the generics market.
Short shares by company, segment and market as a whole
Shares shorted by company Teva Pharmaceutical Industries (TEVA)
Teva Pharmaceutical is one of the world's largest generic drug manufacturers, based in Israel. This chart shows bearish bets. Shorts against Teva are driven by its massive debt, price erosion in the generic market (too many competitors), and ongoing lawsuits related to the opioid crisis in the US.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Teva-Pharmaceutical-Industries-TEVA&v=1772662844811 "Short Shares Chart for the Company Teva Pharmaceutical Industries (TEVA)")
Shares shorted by market segment - Pharma holding
Teva Pharmaceutical (TEVA) is a global leader in generics and a developer of specialty medications (e.g., for migraines). This chart shows the odds against the pharmaceutical sector. The rising odds against the industry reflect investor concerns about ongoing pricing pressure in the generics market and the risks associated with lawsuits (the opioid crisis).
Shares shorted by the overall market
Teva Pharmaceutical is one of the world's largest generic drug manufacturers. Their business should be stable, as people always get sick. However, this chart reflects general market pessimism. When the market is in turmoil, investors may avoid Teva due to its specific problems (massive debt, lawsuits), which become even more dangerous during a crisis.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Teva Pharmaceutical Industries (TEVA)
Teva is a global generic drug giant struggling to survive under the weight of massive debt and opioid lawsuits. This oscillator shows extremes. A successful launch of a new brand-name drug or news of a lawsuit settlement could trigger an explosive rally (above 70). Negative news would send it crashing into deep oversold territory (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Teva-Pharmaceutical-Industries-TEVA&v=1772662844919 "RSI 14 indicator chart for the company's stock Teva Pharmaceutical Industries (TEVA)")
RSI 14 Market Segment - Pharma holding
Teva Pharmaceutical is one of the world's largest producers of generic drugs, making medications more affordable. They also develop their own drugs. This chart reflects the overall health of the generics and pharmaceuticals sector. It helps assess whether the entire sector is oversold due to pricing pressure or legal risks (such as opioid lawsuits).
RSI 14 for the overall market
Teva (TEVA) is one of the world's largest producers of generics (drug analogs) and some brand-name medications. It operates in the healthcare sector. This chart shows the overall market temperature. In times of panic, investors may look to the generics sector as a "defensive" option, as demand for medications is stable. However, TEVA faces its own internal challenges.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast TEVA (Teva Pharmaceutical Industries)
Teva Pharmaceutical is one of the world's largest generic drug manufacturers, which also has a portfolio of brand-name medications (for example, for migraines). This chart reflects analysts' opinions on the company's ability to manage its massive debt, pricing pressure in the generics market, and risks associated with opioid lawsuits.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-TEVA-Teva-Pharmaceutical-Industries&v=1772662844976 "A chart showing analyst consensus forecasts for the expected stock price. TEVA (Teva Pharmaceutical Industries)")
The difference between the consensus estimate and the actual stock price TEVA (Teva Pharmaceutical Industries)
Teva is a global leader in generic drug production, providing volume but low margins. They also have branded medications for migraines and schizophrenia. This chart shows how analysts assess their ability to manage their massive debt and stabilize their generics business. It reflects the gap between their target price and the current price.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-TEVA-Teva-Pharmaceutical-Industries&v=1772662845010 "A chart showing the difference between the consensus forecast and the actual stock price. TEVA (Teva Pharmaceutical Industries)")
Analyst consensus forecast for stock prices by market segment - Pharma holding
Teva is one of the world's largest generic drug manufacturers, also producing original-brand drugs. The company is addressing its debt issues. This chart shows analysts' overall expectations for "big pharma." It reflects whether experts believe the generics market is stable or anticipate pricing pressure.
Analysts' consensus forecast for the overall market share price
Teva (TEVA) is one of the world's largest generic drug manufacturers and a developer of original medications, such as those for migraine treatment. Their mission is to make medicines accessible. This chart shows the general sentiment of experts. It reflects analysts' overall confidence in the stability of the global healthcare system.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Teva Pharmaceutical Industries
Teva Pharmaceutical is one of the world's largest generic drug manufacturers. The company suffered a severe crisis due to massive debt and lawsuits (opioids). It is currently undergoing restructuring. This chart tells the story of the reversal. It reflects the market's confidence that the new management will be able to manage debt and stabilize generic prices while simultaneously promoting its branded drugs.
AKIMA Market Segment Index - Pharma holding
Teva is one of the world's largest generic drug manufacturers, also operating a specialty business (the migraine drug Ajovy). This aggregate metric evaluates companies. The chart shows the sector average. This benchmark provides insight into how Teva's low-margin, yet scalable, generic model (and its debt) differentiates it from the average pharmaceutical company.
The AKIM Index for the overall market
Teva is one of the world's largest producers of generics (copies of drugs). The company also has a portfolio of original-brand drugs. It's a low-margin, but high-volume business. This chart, reflecting the market average, provides a macro backdrop. It helps assess how Teva, while addressing its debt issues, fits into the overall macroeconomic picture affecting the healthcare sector.
